Literature DB >> 19651493

Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones.

Anna Marchese1, Laura Gualco, Elisabetta Maioli, Eugenio Debbia.   

Abstract

For many years meticillin-resistant Staphylococcus aureus (MRSA) has been considered a typical nosocomial pathogen. Recently, MRSA has emerged as a frequent cause of infections in the community. A multicentre surveillance study was carried out in the Ligurian area of Italy to evaluate the incidence, molecular nature and susceptibility patterns of MRSA strains circulating among outpatients. The genetic background of MRSA strains was analysed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Determination of antimicrobial susceptibility patterns, staphylococcal cassette chromosome mec (SCCmec) type, accessory gene regulator (agr) group and Panton-Valentine leukocidin (PVL) production was also performed. In total, 12 (6.4%) of 188 S. aureus isolates collected during 2006-2007 were found to be MRSA by phenotypic and genotypic methods. Analysis of isolates by PFGE showed that the majority of strains (11/12) belonged to two well-known international clones (EMRSA-15 and USA300) and their variations. High variability regarding SCCmec IV subtypes, susceptibility patterns and PVL toxin production were found among members of the USA300 clonal group, even when displaying the same PFGE profiles. The remaining MRSA strain belonged to sequence type (ST) 8, agr group I and carried SCCmec type I. Both community-associated MRSA and healthcare-associated MRSA epidemic international clones circulate among outpatients in our region. It is alarming that members of the most represented clonal group in our collection (USA300) can acquire multiresistance as well as PVL genes. Infection control measures in our area should be improved to avoid the selection of microorganisms displaying both traits simultaneously as well as the spread of these epidemic international clones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651493     DOI: 10.1016/j.ijantimicag.2009.06.016

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

1.  Molecular epidemiology of Panton-Valentine leukocidin-positive Staphylococcus aureus in Spain: emergence of the USA300 clone in an autochthonous population.

Authors:  Raquel Blanco; Anne Tristan; Guillermo Ezpeleta; Anders Rhod Larsen; Michèle Bes; Jérôme Etienne; Ramon Cisterna; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

2.  Enhanced discrimination of highly clonal ST22-methicillin-resistant Staphylococcus aureus IV isolates achieved by combining spa, dru, and pulsed-field gel electrophoresis typing data.

Authors:  Anna C Shore; Angela S Rossney; Peter M Kinnevey; Orla M Brennan; Eilish Creamer; Orla Sherlock; Anthony Dolan; Robert Cunney; Derek J Sullivan; Richard V Goering; Hilary Humphreys; David C Coleman
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

3.  Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India.

Authors:  Namita D'Souza; Camilla Rodrigues; Ajita Mehta
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

4.  DNA microarray-based characterisation of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy.

Authors:  A Sanchini; F Campanile; M Monaco; V Cafiso; J-P Rasigade; F Laurent; J Etienne; S Stefani; A Pantosti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-17       Impact factor: 3.267

5.  In vivo efficacy of ceftaroline fosamil in a methicillin-resistant panton-valentine leukocidin-producing Staphylococcus aureus rabbit pneumonia model.

Authors:  Delphine Croisier-Bertin; Davy Hayez; Sonia Da Silva; Delphine Labrousse; Donald Biek; Cedric Badiou; Oana Dumitrescu; Pascal Guerard; Pierre-Emmanuel Charles; Lionel Piroth; Gerard Lina; Francois Vandenesch; Pascal Chavanet
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

6.  Contribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus.

Authors:  Teresa A Figueiredo; Ana Madalena Ludovice; Rita G Sobral
Journal:  Microb Drug Resist       Date:  2014-05-05       Impact factor: 3.431

7.  High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries.

Authors:  A Tavares; M Miragaia; J Rolo; C Coelho; H de Lencastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-21       Impact factor: 3.267

Review 8.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

9.  Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period.

Authors:  Caterina Mammina; Cinzia Calà; Celestino Bonura; Paola Di Carlo; Aurora Aleo; Teresa Fasciana; Anna Giammanco
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-06-19       Impact factor: 3.944

10.  Epidemic spread of ST1-MRSA-IVa in a neonatal intensive care unit, Italy.

Authors:  Mario Giuffrè; Domenico Cipolla; Celestino Bonura; Daniela Maria Geraci; Aurora Aleo; Stefania Di Noto; Federica Nociforo; Giovanni Corsello; Caterina Mammina
Journal:  BMC Pediatr       Date:  2012-06-08       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.